activesellsec_filings

COUR 10-Q report for 2025-09-30

This play covers Coursera, Inc.’s Form 10‑Q for the quarter ended September 30, 2025. The filing includes condensed consolidated financial statements, MD&A, risk-factor and other disclosures. Key reported items: revenue $194.2M (Q3 2025), cash and cash equivalents $797.7M (9/30/2025), deferred revenue $179.0M (current + noncurrent), and net loss $8.6M for the quarter ($24.2M year-to-date).

Confidence
60 / 100
Assets
1
Authors
1
Outcome
open

Linked assets

COUR — Coursera, Inc. (NYSE: COUR). The 10‑Q provides quarterly financial statements and selected footnote disclosures, including balance sheet, statement of operations, cash flows, and notes on accounting policies and segment reporting.

COURsellopen

Coursera, Inc. (NYSE: COUR) — Form 10‑Q for quarter ended September 30, 2025. Filing includes condensed consolidated balance sheet, statements of operations, comprehensive loss, cash flows, and notes. Reported Q3 2025 revenue $194.2M, gross profit $106.0M, net loss $8.6M, cash & cash equivalents $797.7M, total assets $995.3M, total liabilities $355.8M, total stockholders’ equity $639.5M.

Confidence: 60 / 100Start: $8.28Latest: $5.74Return: 30.74%

The 10‑Q is a comprehensive, unaudited quarterly report that provides verified financial statements and detailed notes. It shows sequential revenue growth (Q3 2025 revenue $194.2M vs. Q3 2024 $176.1M), a quarterly net loss of $8.6M, and a strong cash balance ($797.7M as of 9/30/2025). The filing also documents changes in segment reporting (Consumer and Enterprise) following a CEO transition and confirms outstanding share count (~166.2M shares). Use these reported metrics and footnote disclosures to reassess valuation, dilution and liquidity risk before considering trade execution.

Source proof

Source proof: Strong source proof | 1 directional asset | 1 supporting author | headline-like title review

Primary source: Coursera, Inc. Form 10‑Q for the quarter ended September 30, 2025 (SEC filing / condensed consolidated financial statements and notes). Numbers and line items are taken directly from the filing’s unaudited statements and accompanying notes.

SNBR 10-Q report for 2026-04-04
Sleep Number Corp · May 12, 2026, 3:06 AM EDT

This excerpt is only the cover page/header of Sleep Number’s Form 10-Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.

View source
SOUN 10-Q report for 2026-03-31
SOUNDHOUND AI, INC. · May 11, 2026, 5:28 PM EDT

The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high-confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.

View source
WEAT 10-Q report for 2026-03-31
Teucrium Commodity Trust · May 11, 2026, 5:19 PM EDT

The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As-is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).

View source
ACHR 10-Q report for 2026-03-31
Archer Aviation Inc. · May 11, 2026, 5:01 PM EDT

This excerpt is essentially the cover page of Archer Aviation’s Form 10‑Q for the quarter ended 2026‑03‑31 (issuer identity, exchange listing, and securities outstanding). It contains no operating/financial results, guidance, liquidity details, backlog, or risk-factor updates—so it is minimally actionable for trading beyond basic security identifiers and a generic dilution/optionality consideration from warrants.

View source
CLSK 10-Q report for 2026-03-31
CLEANSPARK, INC. · May 11, 2026, 4:58 PM EDT

This excerpt is essentially the cover page of CleanSpark, Inc.’s Form 10-Q for the quarter ended March 31, 2026. It contains identifiers (CIK/file no.), listing venue, and security descriptions (common stock and redeemable warrants with specific exercise terms), but no operating/financial results, guidance, risks, or MD&A detail. Actionability is therefore limited to capital-structure/dilution considerations around the listed warrant.

View source
ASTS 10-Q report for 2026-03-31
AST SpaceMobile, Inc. · May 11, 2026, 4:40 PM EDT

This excerpt of AST SpaceMobile’s 10‑Q is largely SEC cover-page/boilerplate (registrant info, exchange listing, filing compliance) and contains no financial results, guidance, liquidity, risk-factor updates, or operating metrics. As provided, it does not create a clear tradable catalyst beyond confirming continued reporting/listing status.

View source
SMCI 10-Q report for 2026-03-31
Super Micro Computer, Inc. · May 11, 2026, 4:38 PM EDT

This excerpt only includes the cover page of Super Micro Computer, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It confirms the filing, issuer identity, listing (Nasdaq), and ticker (SMCI), but contains no financial results, guidance, risks, or MD&A content to support a directional investment view.

View source
ABCL 10-Q report for 2026-03-31
AbCellera Biologics Inc. · May 11, 2026, 4:18 PM EDT

The provided text is only the cover/header portion of AbCellera Biologics Inc.’s Form 10‑Q for the quarter ended March 31, 2026 (identifying info, exchange listing, filing status). It contains no financial statements, guidance, risk updates, material events, MD&A, cash runway, pipeline/program updates, or disclosures that would support a differentiated trading view.

View source

Supporting authors

Prepared from the company’s filed Form 10‑Q. Author count: 1 (document metadata). No external analyst commentary included.

Unlock full thesis monitoring

Action recommended: sell. Use the filing’s disclosed results and capital-structure details to reassess position sizing and timing; review MD&A and risk factors in the full 10‑Q for any updates to guidance, liquidity assumptions, or material contingencies before executing trades.